Concepedia

Kentaro Miyazaki

KM

Statistics

Publications

3

Citations

86

H-Index

3

Active since

2019

Affiliations

Astellas Pharma (Japan)(Current)

Astellas Pharma (China)

Zhongda Hospital Southeast University

Chinese Academy of Medical Sciences & Peking Union Medical College

Astellas Pharma (United States)

Kentaro Miyazaki is an author at Astellas Pharma (Japan) specializing in medicine, menopause pharmacotherapy, and menopause hormone therapy.

Publications per year

2019–2024

3

Publications

3

Efficacy and safety of ASP1707 for endometriosis-associated pelvic pain: the phase II randomized controlled TERRA study

Thomas D’Hooghe, Takao Fukaya, Yutaka Osuga et al. · Human Reproduction · 2019 · 43 citations · Full text

, , +17

Efficacy and safety of fezolinetant for moderate to severe vasomotor symptoms associated with menopause among women in East Asia: a phase 3 randomized study (MOONLIGHT I)

Xiangyan Ruan, Wenpei Bai, Mulan Ren et al. · Journal of International Medical Research · 2024 · 26 citations · Full text

, , +15

Long-term safety of fezolinetant in Chinese women with vasomotor symptoms associated with menopause: the phase 3 open-label MOONLIGHT 3 clinical trial

Yu Qi, Ming Fang, Jiezhi Ma et al. · Journal of International Medical Research · 2024 · 17 citations · Full text

, , +16

1–3 of 3